Compare Enveric Biosciences Inc (ENVB) vs Alliant Energy Corporation (LNT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Alliant Energy Corporation — how do they compare? Enveric Biosciences Inc trades at $1.37 (market cap $5.32M), while Alliant Energy Corporation trades at $74.63 (market cap $19.25B). The key difference: Alliant Energy Corporation is far larger — about 3618.4× Enveric Biosciences Inc's market cap, and Alliant Energy Corporation pays a 2.8% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | LNT | |
|---|---|---|
Market Cap | $5.32M | $19.25B |
Sector | Health | Utilities |
52-Week High | $17.40 | $78.03 |
52-Week Low | $1.28 | $62.87 |
Enterprise Value | $408.82K | $30.98B |
Dividend Yield | — | 2.8% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.38, up 4.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported a net loss of $8.77M for 2025, though it beat EPS estimates in all four quarters. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003, including IND-enabling studies and positive preclinical results.
Outlook hinges on clinical progress, with 75% analyst buy ratings supporting potential upside, but high financial losses and negative ROE/ROA pose significant risks. Investors face volatility from regulatory developments and funding needs, making it speculative despite positive sentiment from recent operational updates.
Alliant Energy (LNT) trades at $75.34, down 1.27% today, with a bullish technical signal from moving averages. The stock shows strong fundamentals with 18.58% net income margin and consistent earnings beats in recent quarters. Analyst consensus is positive with a $78.50 price target and 52% buy ratings. The company's $13.4B clean energy investment plan supports long-term growth amid rising data center demand.
LNT offers steady utility growth with dividend income, though increasing debt levels and regulatory risks require monitoring. The stock presents a balanced opportunity for income and capital appreciation investors, with technical support at $74 providing near-term stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light, serving nearly 1 million electricity and natural gas customers and approximately 420,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
Read more on LNT →
